Skip to main content
Signal8

NeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial Pain

$NMTCPress releaseOct 27, 2026, 8:00 AM ETRead the release

NeuroOne highlighted a New York Post feature on the world's first patient treated with its FDA 510(k)-cleared OneRF Trigeminal Nerve Ablation System at University Hospitals in Cleveland. The patient experienced immediate and lasting relief from trigeminal neuralgia after a minimally invasive procedure lasting as little as 20-30 minutes.

Key figures

Procedure duration minutes
20 to 30

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.